Search

Search

Log in or registerMenuClose

Search

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

Legal 500 Trust Centre
Contact Us

Market Intelligence
Search

Your search for ‘Smart & Biggar’ returned 2,497 results

Use advanced search filters to refine your search

Search

Advanced search filters

Topics

Search for topics

Countries

Search for countries

Contributor

Search to show contributors

Start typing to add contributors

Content type

Any
Article
Podcast
Video

Sort by

Article
Costco Pharmacies Receive $7.25M Penalty For Accepting Drug Rebates
The Rebate Order at issue states for means that the benefit is linked directly or indirectly to listed or interchangeable products sold or offered for sale to the pharmacy.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Article
FCA Provides Guidance On Standard For Leave To Appeal Interlocutory PMNOC Decisions
On December 3, 2020, the Federal Court of Appeal released its first decision providing guidance on the standard for obtaining leave to appeal interlocutory decisions under section 6.11(1) of the...
CanadaFood, Drugs, Healthcare, Life Sciences

Smart & Biggar

Federal Court Of Appeal Affirms Minister Of Health Reasonable In Concluding Successor Second Person Was Entitled To Benefit Of NOA Served By Predecessor

On May 26, 2023, the Minister of Health determined that Biosimilar Collaborations Ireland Limited was entitled to the benefit of section 5 of the Patented Medicines (Notice of Compliance) Regulations (Regulations)...

CanadaFood, Drugs, Healthcare, Life Sciences

Federal Court Of Appeal Dismisses Appeal Of SPRAVATO "Innovative Drug" Decision

On November 10, 2021, the Minister of Health refused to reassess its decision that Janssen's esketamine hydrochloride product (SPRAVATO)...

CanadaFood, Drugs, Healthcare, Life Sciences

Health Canada Provides Clarifications On Application Of The Definition Of Canadian Reference Product Based On Dormant Status

We previously reported Health Canada's March 27, 2023 consultation on its proposed application of the definition of Canadian reference product (CRP) based on "Dormant Status" under s. C.08.001.1(b)...

CanadaFood, Drugs, Healthcare, Life Sciences

Health Canada Releases Its Health Product Highlights, Annual Drug Submission Performance Reports And OPML Statistical Report

Health Canada released a number of reports over the summer: Annual Health Product Highlights for 2021, which provides an overview of new health products, including drugs and medical devices...

CanadaFood, Drugs, Healthcare, Life Sciences

Health Canada Seeks Feedback On Phased Implementation Of The Incorporated By Reference List For Ministerial Reliance Order

As previously reported, Health Canada has proposed a Ministerial Reliance Order that would allow Health Canada to rely on decisions of foreign regulatory authorities (FRAs). Health Canada has proposed that the Reliance Order will come into force in summer 2026, at which point Health Canada will consult on an applicable guidance document.

CanadaFood, Drugs, Healthcare, Life Sciences

L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

L'Alliance pharmaceutique pancanadienne (« APP ») a récemment annoncé qu'elle officialisait et lançait son processus de négociation ciblé (« PNC ») révisé.

CanadaFood, Drugs, Healthcare, Life Sciences

Mise à jour sur la proposition d'arrêté ministériel relatif à la confiance

Comme nous l'avons indiqué le mois dernier, la ministre de la Santé a lancé une consultation sur une proposition d'arrêté ministériel relatif à la confiance qui permettrait...

CanadaFood, Drugs, Healthcare, Life Sciences

New Court Proceedings - July 2022

New Court Proceedings.

CanadaFood, Drugs, Healthcare, Life Sciences

pCPA Announces New Three-year Pricing Initiative Agreement For Generic Drugs With CGPA, Appointment Of Douglas Clark As Its First CEO

The pan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) have agreed to a new three-year pricing initiative for generic drugs, effective October 1, 2023.

CanadaFood, Drugs, Healthcare, Life Sciences

PCPA Introducing Revisions To Pathway For Non-complex Drug Negotiations

The pan-Canadian Pharmaceutical Alliance (pCPA) recently announced it is formalizing and introducing revisions to the Targeted Negotiation Process (TNP).

CanadaFood, Drugs, Healthcare, Life Sciences

PMPRB Publishes Annual Meds Pipeline Monitor Report

The Patented Medicine Prices Review Board (PMPRB) recently published its Meds Pipeline Monitor 2022 report, which highlights medicines in the pipeline that may impact future clinical...

CanadaFood, Drugs, Healthcare, Life Sciences

PMPRB Update: Revised Compliance Timelines For Grandfathered And Gap Medicines And Proposed Regulatory Amendments Directed To CSPs

On April 16, 2021, in view of COVID-19, the Patented Medicine Prices Review Board (PMPRB) reversed its position on compliance timelines for Grandfathered and Gap medicines: compliance with the...

CanadaFood, Drugs, Healthcare, Life Sciences

Proposed Amendments To Ontario Regulations To Streamline Administrative Process, Change OCT Payment Limit, And Reduce Government Payments To Pharmacies

On October 28, 2019, the Ontario Ministry of Health and Long-Term Care (the Ministry) published proposed changes to Regulations made under the Ontario Drug Benefit Act (ODBA)...

CanadaFood, Drugs, Healthcare, Life Sciences

Self-Care Regulations To Get A Make Over

Health Canada not only regulates prescription drugs sold in Canada, but also it regulates a wide variety of "self-care" products that can be purchased at health food stores, pharmacies and grocery stores.

CanadaFood, Drugs, Healthcare, Life Sciences

Special Access Program And Emergency Drug Release Program Amendments In Force

On September 28, 2020, the Regulations Amending Certain Regulations Made under the Food and Drugs Act (Sale of a New Drug for Emergency Treatment) (Regulations) came into force.

CanadaFood, Drugs, Healthcare, Life Sciences

Updates From CADTH: Improvements To CADTH Reimbursement Review Process, Increased Fees And New Formulary Management Expert Committee Pilot

The Canadian Agency for Drugs and Technologies in Health (CADTH) announced upcoming improvements to its Reimbursement Review process. CADTH will review its current process to identify...

CanadaFood, Drugs, Healthcare, Life Sciences

What's In A Name? Biosimilar Nonproprietary Names

The U.S. federal government created a specially-designed, abbreviated biosimilar approval pathway

CanadaFood, Drugs, Healthcare, Life Sciences

A Long And Winding Road: Canada Nears The End Of An Ambitious Project To Modernize Patent, Trademark And Industrial Design Laws

On July 30, 2019, Canada acceded to the Patent Law Treaty.

CanadaIntellectual Property

Showing 601–620 of 2497 results

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics